ArticleMDM policy & practice

Cost-Effectiveness of Saxagliptin Compared With Glibenclamide as a Second-Line Therapy Added to Metformin for Type 2 Diabetes Mellitus in Ethiopia.

Mengistu Bekele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.